High doses of the commonly used herbicide atrazine have been shown to suppress luteinizing hormone (LH) release. To determine whether atrazine alters the function of gonadotropinreleasing hormone (GnRH) neurons, we examined the effects of atrazine on GnRH neuronal activation and the subsequent release of LH normally associated with ovulation. Ovariectomized adult Wistar rats were administered atrazine (50, 100, or 200 mg/kg of body weight daily by gavage) or vehicle for 4 days. Animals were primed with estrogen and progesterone to induce an evening LH surge. Blood samples were obtained over the afternoon and evening using an indwelling right atrial cannula, and plasma was assayed for LH and FSH. Another cohort of animals was transcardially perfused in the afternoon to examine GnRH activation using FOS immunoreactivity. Results of these studies show that 4-day treatment with atrazine resulted in a significant reduction in the magnitude of the LH and FSH surges, and this corresponds to a decrease in GnRH neurons expressing FOS immunoreactivity. To determine if the effects of atrazine were long lasting, additional studies were performed examining LH levels and GnRH activation 2 days and 4 days after atrazine withdrawal. Within 4 days (but not 2 days) after cessation of atrazine treatment, measures of hypothalamic-pituitary-gonadal (HPG) activation returned to normal. These data indicate that atrazine affects neuroendocrine function in the female rat by actions at the level of the GnRH neuron and that the acute effects of high doses of atrazine can be reversed within 4 days after withdrawal of treatment.
INTRODUCTION
The chlorotriazine atrazine (2-chloro-4-[ethylamino]-6-[isopropylamino]-s-tri-azine) is one of the most commonly used herbicides in the United States, with more than 50 million pounds applied annually [1] . Its primary use is to control weeds in corn and sorghum fields before and after emergence. In plants, its principal mode of action is to inhibit the electron transport necessary for photosynthesis [2] .
Atrazine and its primary metabolites such as diaminochlorotriazine have been shown to inhibit the preovulatory surge of luteinizing hormone (LH) in rodent models [3] [4] [5] [6] . In addition, atrazine treatment can prolong the estrous cycle [3, 5, [7] [8] [9] , delay puberty onset [10, 11] , and result in a reduction in testosterone levels in males [12] [13] [14] . These effects of atrazine on reproductive function may all be mediated by suppression of gonadotropin-releasing hormone (GnRH) or LH release. However, whether these effects of atrazine occur at the level of the pituitary or brain is still not well explored.
We have recently shown that atrazine treatment decreases LH pulse frequency and increases LH pulse amplitude in ovariectomized rats without changing pituitary sensitivity to a GnRH receptor agonist [15] . In the absence of changes in pituitary sensitivity to GnRH, changes in LH secretion accurately reflect changes in GnRH release [16] [17] [18] , suggesting a neural site of the action of atrazine. Consequently, we examined the effects of atrazine on the estrogen (E)-and progesterone (P)-induced LH surge in freely moving ovariectomized rats to determine if the inhibition of LH secretion by atrazine coincides with a reduction in GnRH neuronal activation. The immediate early gene product FOS (cFOS) was colocalized in GnRH neurons as a measure of cellular activity. Furthermore, we performed withdrawal studies to determine whether LH levels and measures of GnRH neuronal activation would return to control levels following the termination of atrazine treatment.
MATERIALS AND METHODS

Animals
All animal surgeries and experimental protocols were approved by the Animal Care and Use Committee at Colorado State University and were carried out in accord with National Institutes of Health and Association for Assessment and Accreditation of Laboratory Animal Care International guidelines. Young adult female enhanced green fluorescent protein (eGFP)-GnRH Wistar rats (60-90 days old) were obtained from a breeding colony at Colorado State University. These animals express eGFP driven by the GnRH promoter. The colony was established through a generous gift from Masakatsu Kato and Yasuo Sakuma from Nippon Medical School, Tokyo, Japan, and has been characterized previously [19] . Animals were single housed in the Colorado State University vivarium and were maintained on a 12D:12L schedule (lights on at 0700 h) with ad libitum access to food and water. All animals were ovariectomized and were allowed at least 1 wk to recover before treatment commenced.
Experiment 1: Effects of Atrazine on Hormone-Induced LH and Follicle-Stimulating Hormone Surges
To determine if atrazine treatment alters the EþP-induced LH and folliclestimulating hormone (FSH) surges, animals were administered atrazine (once daily for 4 consecutive days between 1000 and 1100 h; doses of 0, 50, 100, or 200 mg/kg of body weight; n ¼ 5-8/group) by gavage in 1% carboxymethylcellulose sodium salt (CBC). On the second day of atrazine treatment, intraatrial cannulae were implanted. To induce an LH surge, animals were injected with 17b-estradiol-3-benzoate (EB) s.c. (40 lg/kg of body weight in safflower oil between 1000 and 1100 h) for 3 consecutive days beginning on the second day of atrazine treatment. On the third day of EB treatment and the final day of atrazine treatment, animals were injected with P s.c., (2 mg/animal in safflower oil) at 1100 h to induce an afternoon LH surge. This hormone treatment paradigm has been utilized previously and has been shown to effectively induce a preovulatory-like surge of LH [20] .
On the afternoon of the fourth day of atrazine treatment, blood samples (150 ll) were taken at 1-h intervals in conscious freely moving rats. Rats were kept in their home cages during the sampling session, which lasted for 9 h commencing at 1300 h (lights out at 1900 h). Following each sample, blood volume and hematocrit were maintained by infusing each animal with an equivalent amount of red blood cells and saline obtained from the previous sample of the same rat. Plasma was removed from each sample and frozen for later analysis of LH and FSH using radioimmunoassay.
Experiment 2: Effects of Atrazine on GnRH Neuronal Activation
Ovariectomized animals were treated with atrazine (once daily for 4 consecutive days between 1000 and 1100 h; doses of 0, 50, 100, or 200 mg/kg) and were EBþP primed as already described. Near the peak of the predicted LH surge (1700 h in our colony), animals (n ¼ 4-6/group) were anesthetized with ketamine and perfused transcardially with 4% paraformaldehyde. After fixation, brains were removed, postfixed in 4% paraformaldehyde overnight, and then placed in 30% sucrose for cryoprotection. After sucrose infiltration, brains were cut on a cryostat at a thickness of 35 lm. Every fourth section was processed for GnRH and cFOS using immunohistochemistry [20, 21] .
To determine if atrazine alone would have a stimulatory effect on GnRH neuronal activation, a second cohort of animals was treated as already described except that no hormones were given to induce GnRH and LH surges. In short, ovariectomized animals were gavaged with 50 mg/kg of atrazine or vehicle for 4 days. On the afternoon of the final day of treatment, animals were anesthetized and perfused, and brains were processed for FOS immunohistochemistry.
Experiment 3: Effects of Atrazine Withdrawal on Hormone-Induced LH Surge and GnRH Activation
To examine the recovery of the EBþP-induced GnRH and LH surges and GnRH neuronal activation after atrazine withdrawal, ovariectomized animals were given a 4-day regimen of atrazine (200 mg/kg) in 1% CBC by gavage. Control animals received CBC only. All treatments were given between 1000 and 1100 h each day. An LH surge was induced in these animals either during the atrazine treatment period (as previously described) or 2 days or 4 days after the cessation of atrazine treatment (n ¼ 4-13/group). To induce an LH surge, animals were injected with EB for 3 consecutive days beginning either on the second day of atrazine treatment, the final day of atrazine treatment, or 2 days after atrazine treatment was terminated. On the third day of EB treatment, animals were injected with P s.c., (2 mg/animal in safflower oil) at 1100 h to induce an afternoon LH surge. On the afternoon of the final day of hormone treatment, blood samples were taken by indwelling cannula beginning at 1300 h and continuing hourly for 9 h.
A second cohort of animals was prepared as already described (n ¼ 8-10/ group) but without the intra-atrial cannula. Near the peak of the LH surge (1700 h in our colony), these animals were perfused transcardially with 4% paraformaldehyde. After fixation, brains were removed and postfixed overnight and then placed in 30% sucrose for cryoprotection until processed for histological examination.
Intra-Atrial Cannulation
To determine the level of LH and FSH secretions in these studies, we used a chronic indwelling cannulation procedure to discretely remove blood samples from freely moving rats while in their own home cage. As described previously [22] , this procedure is a modification of that by Harms and Ojeda [23] and by Garner et al. [24] . Briefly, a cannula of Silastic tubing (0.037-inch outer diameter and 0.020-inch inner diameter; Technical Products of Georgia, Decatur, GA) was inserted into the right atrium via the right jugular vein. The cannula was fixed to the pectoralis major muscle and externalized at the back by tunneling under the skin and allowing the end to hang free. The cannula was sealed with a piece of 23-gauge stainless steel. For blood sampling, a length of polyethylene 50 tubing was attached to the free end of the cannula, and the animal was infused with heparin sodium (100 U; Baxter Healthcare Corp., Deerfield, IL) and allowed to recover for 1 h before sampling commenced. One hundred fifty-microliter samples of blood were taken at discrete intervals via the cannula during the sampling session. We have previously used this paradigm to sample blood from freely moving animals under nonstressful conditions. There was no evidence of dramatic increases in stress hormones such as adrenocorticotropic hormone during sampling [25] .
Immunocytochemistry
To determine the degree of GnRH neuronal activation, immunohistochemical procedures were used to identify c-FOS in eGFP-GnRH neurons. Brains were sectioned at a thickness of 35 lm on a cryostat, and every fourth section was used. For immunohistochemistry, sections were removed from cryopreservative solution [26] and repeatedly washed in 0.1 M PBS. The procedure was carried out on free-floating sections at room temperature. The sections were incubated in PBS containing 10% normal goat serum (Jackson Laboratories, Inc., West Grove, PA) and 0.4% Triton X-100 (Sigma; St. Louis, MO) (PBSTX) for 1 h. Sections were then incubated in PBSTX for 16 h with a rabbit polyclonal antibody against FOS (sc-52, 1:5000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Following incubation, sections were washed and then placed in a solution of PBSTX with biotinylated goat antirabbit IgG (1:400; Vector Labs, Burlingame, California) for 1 h. The sections were subsequently washed and incubated for 1 h in avidin-biotin complex (1:500; Vector Labs). Sections were again washed and then placed in a solution of Cy3 streptavidin (1:200; Jackson Laboratories, Inc.) for 1 h. Sections were visualized for eGFP-GnRH and Cy3-labeled FOS using an LSM 510 Zeiss laser scanning confocal microscope (Carl Zeiss Microscopy, Jena, Germany).
Immunohistochemical controls included the omission of the primary antibody from the immunostaining protocol, which completely eliminated staining for the corresponding antigen. The number and location of eGFPGnRH-positive cells and the percentage of GnRH neurons that colocalized with FOS immunoreactivity were determined by a researcher blinded to treatment conditions. Cells were considered double labeled only if a ring of eGFPpositive cytoplasm completely surrounded a FOS immunoreactivity nucleus through multiple planes of focus.
Radioimmunoassay
Plasma levels of LH and FSH were measured using reagents provided by the National Hormone and Peptide Program. Rat LH-RP3 and FSH-RP2 were used for constructing the respective standard curves. Tracer LH and FSH were iodinated using the chloramine T method by the Colorado State University peptide assay core. The intraassay and interassay coefficients of variation for LH assays were 4.16% and 3.76%, respectively. All FSH values were determined within one assay with an intraassay coefficient of variation of 5.4%.
Data Analysis
ANOVA was performed on all LH and FSH data for all experiments with repeated measures across time and treatment for multiple sequential samples from the same animal. The peak LH or FSH surge amplitude was calculated by determining the peak concentration during the sampling period regardless of timing. The LH or FSH levels were plotted using all time points, and the area under the curve (AUC) for each hormone was determined using Prism 5 software (GraphPad Software, San Diego, CA). The means of the first and last samples were used as baseline values. When significant differences were observed, Dunnett post hoc test was used to determine which experimental groups differed from the controls. The level of statistical significance was set at P 0.05. Numerical values are reported as the mean 6 SEM. The computer program StatView 5.0.1 (SAS Institute Inc., Cary, NC) was used for statistical analysis.
RESULTS
Experiment 1: Effects of Atrazine on Hormone-Induced LH and FSH Surges
Atrazine treatment inhibited the EBþP-induced LH surge at all doses examined compared with the controls (Fig. 1, A-C) . The atrazine-treated animals at all doses demonstrated lowered peak amplitude in the LH surge (Fig. 1B) (F 3,23 ¼ 6.320, P , 0.01). Likewise, atrazine-treated animals demonstrated a reduced AUC for the LH surge compared with the controls (Fig. 1C) (F 3,23 ¼ 10.725, P , 0.01) . All of the animals treated 1100 FORADORI ET AL.
with vehicle (4 of 4) or 50 mg/kg of atrazine (6 of 6) were found to have LH levels that exceeded two SD above baseline. Fewer animals treated with 100 mg/kg (6 of 8) and 200 mg/kg (2 of 5) of atrazine were found to respond to hormone priming. Atrazine treatment also resulted in reduced FSH levels in some but not all measures (Fig. 1, D-F) . Atrazine had no significant effect on the peak FSH levels (Fig. 1E) Atrazine treatment reduced the mean number of GnRH neurons immunoreactive for FOS (F 3,17 ¼ 4.779, P , 0.02). There was no difference between the control groups (23.80 6 5.61) and the 50 mg/kg of atrazine group (21.00 6 5.85) (F 1,7 ¼ 0.12, P ¼ 0.74). Both the control and 50 mg/kg of atrazine groups were elevated above the 100 mg/kg (9.83 6 2.85) and 200 mg/kg (6.17 6 1.62) of atrazine groups, with no differences between the 100 mg/kg and 200 mg/kg doses (F 1,10 ¼ 1.25, P ¼ 0.29). There was no effect of treatment on the mean number of GnRH immunoreactive cells (F 3,17 ¼ 1.36,
To determine if atrazine alone could induce FOS immunoreactivity in GnRH neurons, control animals and animals treated with 50 mg/kg of atrazine were gavaged with atrazine for 4 days, and brains were processed for FOS. Neither atrazine (50 mg/kg) nor vehicle had any effect on FOS immunoreactivity in animals not treated with EBþP. There was little to no FOS immunoreactivity in GnRH neurons in either vehicletreated animals (0.50 6 0.40) or atrazine-treated animals (0.50 6 0.22).
Experiment 3: Effects of Atrazine Withdrawal on Hormone-Induced LH Surge and GnRH Activation
To determine if the effects of atrazine were long lasting, we examined animals for a change in the relative level of the LH surge and GnRH and FOS colocalization following atrazine withdrawal. The hormone-induced LH surge in atrazine-treated animals was again inhibited when measured on the final day of treatment, however, the levels returned to those of control animals within 4 days of termination of treatment (Fig. 3A ) (F 5,41 ¼ 11.55, P , 0.0001). Likewise, GnRH activation was reduced when measured on the final day of treatment but was restored to control levels by 4 days following atrazine 
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withdrawal (Fig. 3B ) (F 5,48 ¼ 8.838, P , 0.0001). As shown in our previous study, atrazine treatment of 200 mg/kg for 4 days significantly reduced the peak LH levels compared with the controls (F 1,10 ¼ 83.91, P , 0.0001). When examined 2 days after atrazine treatment was stopped, LH was significantly lower than in the controls animals (F 1,20 ¼ 20.53, P , 0.0005). However, LH levels of these animals were significantly elevated above LH levels of animals measured on the final day of atrazine exposure (F 1,19 ¼ 10.47, P , 0.005). Four days following atrazine withdrawal, LH levels were not significantly different from those of control animals (F 1,11 ¼ 0.39, P ¼ 0.55) and were significantly elevated above those of animals on the final day of atrazine treatment (F 1,13 ¼ 17.36, P , 0.002) and 2 days after final atrazine treatment (F 1,18 ¼ 4.42, P , 0.05). There were no significant differences between control animals at any time point after gavaging with vehicle (F 2,16 ¼ 0.314, P ¼ 0.7351).
Examination of FOS immunoreactivity in GnRH neurons revealed that atrazine treatment significantly reduced the percentage of GnRH neurons immunoreactive for cFOS on the final day of atrazine treatment (F 1,18 ¼ 29.74, P , 0.0001).
Two days after atrazine withdrawal, FOS immunoreactivity in GnRH neurons was significantly lower compared with the controls (F 1,14 ¼ 7.01, P , 0.02). However, these levels were significantly higher than those of atrazine-treated animals on the final day of treatment (F 1,16 ¼ 5.72, P , 0.05). Four days after atrazine withdrawal, FOS immunoreactivity in GnRH neurons was no longer different from control levels (F 1,16 ¼ 1.24, P ¼ 0.28) and was significantly elevated above the levels from atrazine-treated groups on the final day of treatment (F 1,18 ¼ 17.08, P , 0.001). There was no significant difference between atrazine-treated animals 4 days and 2 days after the final treatment (F 1,16 ¼ 3.51, P ¼ 0.079), and there were no significant differences between control animals at any time point following vehicle gavage (F 2,23 ¼ 0.413, P ¼ 0.67).
DISCUSSION
The data from these experiments demonstrate that acute atrazine exposure has a dramatic effect on the neuroendocrine control of reproductive function in the adult female Wistar rat and that these effects are transient in nature. Atrazine treatment for 4 days significantly reduced the EBþP-induced LH surge. Our results are consistent with atrazine suppression of the hormone-induced LH surge reported by others [3, 4] . In addition, we identified a corresponding attenuation in the degree of GnRH neuronal activation. Subsequent experiments demonstrated that within 4 days of withdrawal of atrazine treatment the LH surge and markers of GnRH activation returned to those levels of vehicle-treated animals.
Atrazine treatment of 200 mg/kg was found to also reduce the level of plasma FSH levels. These findings somewhat contradict the findings by Cooper et al. [3] that multiple doses of atrazine over varying durations had no effect on FSH levels. However, in that study FSH measurements were taken at a single time point and not during a time of hormone-induced FSH release. In the present study, multiple samples were taken from the same animal during a time of hormone stimulation. Indeed, although the peak levels of FSH were not significantly different between treatment groups, the AUC representing cumulative FSH secreted over time was lower in animals treated with 200 mg/kg of atrazine.
There was also discrepancy between the degree of inhibitory actions imposed by atrazine on the hormone-induced LH compared with FSH. In the present study, atrazine treatment at all doses reduced LH surge amplitude, but FSH amplitude was unaffected. Similarly, the AUC of the FSH surge was only significantly reduced when animals were treated with the highest dose of atrazine, whereas all doses of atrazine reduced the AUC of the LH surge. The differential findings between LH and FSH were not altogether surprising. While GnRH promotes secretion of both LH and FSH, the two hormone secretory patterns are regulated by multiple factors, including GnRH pulse frequency [16, 27, 28] . The gonadotropin subunit genes are regulated primarily by GnRH, which is released in a pulsatile manner. Faster GnRH pulse frequencies favor the LH subunit, and slower GnRH pulse frequencies favor the FSH subunit [29] . We have previously shown in ovariectomized Wistar rats that high doses of atrazine reduce GnRH pulse frequency [15] . Therefore, atrazine treatment may have reduced GnRH pulse frequency and therefore differentially increased the synthesis of FSH. Atrazine treatment ultimately leads to an inhibition of GnRH activation and presumably release, as well as subsequent reduction in the LH and FSH levels. However, it is possible that the drop in FSH is not as dramatic as that in LH due to the relative increase in FSH beta subunit synthesis present in the gonadotrophs as a result of the atrazine-induced inhibition in GnRH pulse frequency. Obviously, more work needs to be done to further understand the role of atrazine in disrupting FSH regulation.
In these studies, the reduction in LH and FSH levels following atrazine treatment correlated with a reduction in the percentage of GnRH neurons that express cFOS. In rats, the preovulatory LH surge is triggered by the positive feedback action of estradiol [30] . In addition, the concomitant rise in circulating P levels during the afternoon of proestrus enhances the action of estradiol by increasing the amplitude of the LH surge [31] . Using FOS as a marker for neuronal activation, previous studies [20, 32] have demonstrated that GnRH neurons express FOS only during the afternoon of proestrus or during a steroid-induced LH surge. Administration of pentobarbital, which blocks the LH surge, also blocks FOS expression in GnRH neurons [20] . In contrast, enhancement of the LH surge by administration of P is associated with an increase in the proportion of FOS-containing GnRH neurons [33] . Thus, the amplitude of the LH surge is highly correlated with the number of GnRH neurons containing FOS, suggesting that FOS is a reliable marker for monitoring GnRH activation. However, in the present study treatment with 50 mg/kg of atrazine resulted in a significant reduction in the peak LH levels, but similarly treated animals did not show a statistically significant reduction in the degree of GnRH cells immunoreactive for FOS. To determine if this discrepancy was due to the ability of atrazine to somehow induce FOS expression in GnRH neurons, we treated ovariectomized animals with atrazine or vehicle for 4 days and did not prime the animals to induce a surge. The results demonstrate that atrazine alone does not induce FOS activation in GnRH. Although (as stated previously) FOS is a commonly used marker for cellular activation, its importance as a correlate should not be overstated. The presence of FOS immunoreactivity in a certain number of GnRH neurons does not correspond to a finite amount of GnRH or LH secreted. In addition, these measures of GnRH activation were taken from two different cohorts of animals, one group to measure LH levels over multiple time points and another group to identify the presence of FOS immunoreactivity in GnRH neurons at a single time point. Overall, our findings may suggest a disconnect between GnRH somal stimulation and secretagogue release from terminals. However, further investigation is required.
In the present study, the reduction in FOS immunoreactivity in GnRH neurons was demonstrated by the examination of eGFP fluorescence in an eGFP-GnRH rat model. In addition, dual-immunohistochemistry was used on alternate sections to identify GnRH and FOS immunoreactive cells, and this yielded similar results (data not shown). Using both techniques provides strong evidence that atrazine works through a hypothalamic site of action to inhibit GnRH neuronal activation.
Atrazine and its metabolites are lipid soluble and therefore should cross the blood-brain barrier to directly affect either GnRH neurons or upstream modulators [34] . We have previously shown that atrazine treatment of ovariectomized rats does not change pituitary sensitivity to a GnRH receptor agonist [15] . This suggests that atrazine works at the level of the hypothalamus to inhibit GnRH release. While it is known that GnRH neurons are spontaneously oscillatory and that the GnRH surge is characterized by high-frequency high-amplitude release of GnRH, it is unknown how this scattered group of neurons is synchronized to produce a surge of GnRH. Furthermore, it remains unclear whether atrazine acts directly on GnRH neurons or on one of many neurotransmitter containing neurons in the brain that are known to have a role in controlling the preovulatory surge of GnRH [35, 36] .
Considerable effort has also been engaged to determine if atrazine acts either to stimulate or disrupt E receptor binding [37] . However, most investigations show little or no estrogenic or antiestrogenic activity of atrazine in vivo [4, 38] . Therefore, it is unlikely that atrazine is acting to disrupt GnRH activation through the E receptor.
GnRH triggers the ovulatory surge of LH from the pituitary into the general circulation, an event in the female rat that is initiated on the day of proestrus, typically a few hours before the onset of the dark portion of the photoperiod. The abolition of the LH surge is consistent with an absence of normal ovulation. However, in the present study atrazine treatment resulted in a reduction in the level of the LH surge. It is unknown whether the remaining rise in LH among atrazinetreated intact females would be sufficient to result in ovulation. In addition, it is unknown if atrazine will have an effect on the sequential secretion of ovarian E and P, as well as their subsequent influence on neuronal activity required to synchronize changes in the sexual behavior and physiological processes associated with ovulation. Cooper et al. [3] have shown that atrazine (300 mg/kg) administered to intact Long-EFFECTS OF ATRAZINE ON HPG AXIS Evans female rats on the day of vaginal proestrus can attenuate the amplitude of E-induced LH without affecting ovulation. However, a longer duration of atrazine treatment at this dose resulted in a disruption of cyclicity and subsequent ovulations.
To better understand the possible mechanism involved in atrazine inhibition of GnRH activation and reduced LH levels, we investigated the effects of atrazine withdrawal. This was done to determine if the effects were transient or if atrazine exposure at these levels results in long-lasting changes in the ability of the HPG axis to be stimulated into triggering the preovulatory GnRH and LH surges. Four days after the cessation of atrazine treatment, the hormone-induced LH surge and the percentage of GnRH neurons immunoreactive for FOS had returned to control levels. Intermediate responses were seen after 2 days of withdrawal. These findings indicate that atrazine treatment inhibition of GnRH activation and LH levels is transient and does not result in permanent measurable changes in the responsiveness of the HPG to stimulation. Although these effects can be reversed after an acute high-dose exposure to atrazine, it is unknown whether reversal can occur after more chronic atrazine treatment. However, the present treatment paradigm of acute high-dose exposure may better model the application and corresponding environmental exposure to applicators and immediate runoff from application sites [39] [40] [41] .
In conclusion, atrazine treatment inhibited the hormoneinduced LH surge and GnRH neuronal activation, an effect that was transient and no longer present 4 days after withdrawal. Thus, the inhibition of the HPG axis and the disruption of cyclicity in female rats treated with atrazine are likely to be mediated by interference with central mechanisms controlling GnRH activation in the preoptic area and hypothalamus. Although the doses of atrazine used in this study are high, the data support the hypothesis that the brain is the primary target mediating the effects of atrazine on LH release in the rat.
